Kaiser Permanente Southern California joins the HAPO study.

It is 1 of 15 sites in the world selected for the original Hyperglycemia and Adverse Pregnancy Outcomes study.

The HAPO Follow-Up study recruits patients from 2013 to 2016, and the third phase begins in 2023 to assess cardiovascular health in children of mothers with diabetes.